Sonali Gupta
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Sonali Gupta has a total of 44 co-authors. Here are the top co-authors by number of shared publications:
- Pradeep Goyal
Department of Radiology, St. Vincent's Medical Center, Bridgeport, CT
8 shared publications Pradeep Goyal
Department of Radiology, St. Vincent's Medical Center, Bridgeport, CT 06606, USA
6 shared publicationsJoseph Mattana
Department of Medicine, St.Vincent's Medical Center, Bridgeport, Conn
5 shared publicationsBelinda Jim
Division of Nephrology, Department of Medicine, Albert Einstein College of Medicine, Jacobi Medical Center, Bronx, NY
2 shared publications- Joseph Mattana
Department of Medicine, St. Vincent's Medical Center, Bridgeport, CT, USA
2 shared publications Aastha Vasa
Division of Nephrology, Department of Medicine, Albert Einstein College of Medicine/Montefiore Medical Center, Bronx, NY
1 shared publication
Latest Publications
- Open Access
- 15 October 2025
- Published by Elsevier in Kidney Medicine
- Vol. 7 (12) , 101147
Health Care Utilization Among Pregnant Women With Pre-existing Kidney Disease: A Retrospective Cohort Analysis
- 15 October 2025
- Published by Elsevier in Kidney Medicine
- Vol. 7 (12) , 101147
Open AccessHealth Care Utilization Among Pregnant Women With Pre-existing Kidney Disease: A Retrospective Cohort Analysis
- 16 November 2022
- Published by Wolters Kluwer Health in Current Opinion in Nephrology and Hypertension
- Vol. 32 (2) , 153-164
Hypertension in Pregnancy: What We Now Know
Purpose of review: Hypertensive disorders of pregnancy remain a highly morbid condition that affects both the mother and fetus, complicate approximately 10% of pregnancies worldwide, and contribute to immediate and long-term cardiovascular outcomes. There is still much to learn regarding pathogenesis and treatment goals. Recent findings: There is updated information on the pathogenesis of preeclampsia and treatment thresholds for HTN in pregnancy. l-Kynurenine, a metabolite of the essential amino acid l-tryptophan, has been implicated in preeclampsia as decreased levels were found in a uninephrectomized pregnant mouse model of preeclampsia, where replacement of l-kynurenine rescued the preeclamptic state. Further, data from CHIPS (The Control of HTN in Pregnancy Study) and CHAP (Chronic HTN and Pregnancy) trials demonstrate not only the safety of lowering blood pressure to either a diastolic goal of 85 mmHg (CHIPS) or less than 160/105 mmHg (CHAP) without detriment to the fetus but the CHAPS trial has also shown a decrease in the rate of preeclampsia in the treatment group. Summary: We will summarize the different types of hypertensive disorders in pregnancy, updates on the pathogenesis of preeclampsia, and appropriate HTN management based on the latest evidence in order to better care for mother and child.
- 16 November 2022
- Published by Wolters Kluwer Health in Current Opinion in Nephrology and Hypertension
- Vol. 32 (2) , 153-164
Hypertension in Pregnancy: What We Now Know
Purpose of review: Hypertensive disorders of pregnancy remain a highly morbid condition that affects both the mother and fetus, complicate approximately 10% of pregnancies worldwide, and contribute to immediate and long-term cardiovascular outcomes. There is still much to learn regarding pathogenesis and treatment goals. Recent findings: There is updated information on the pathogenesis of preeclampsia and treatment thresholds for HTN in pregnancy. l-Kynurenine, a metabolite of the essential amino acid l-tryptophan, has been implicated in preeclampsia as decreased levels were found in a uninephrectomized pregnant mouse model of preeclampsia, where replacement of l-kynurenine rescued the preeclamptic state. Further, data from CHIPS (The Control of HTN in Pregnancy Study) and CHAP (Chronic HTN and Pregnancy) trials demonstrate not only the safety of lowering blood pressure to either a diastolic goal of 85 mmHg (CHIPS) or less than 160/105 mmHg (CHAP) without detriment to the fetus but the CHAPS trial has also shown a decrease in the rate of preeclampsia in the treatment group. Summary: We will summarize the different types of hypertensive disorders in pregnancy, updates on the pathogenesis of preeclampsia, and appropriate HTN management based on the latest evidence in order to better care for mother and child.
- Open Access
- 11 April 2020
- Published by Springer Nature in Cureus
- Vol. 12 (4) , e7639
An Interesting Case of Congenital Intrahepatic Porto-hepatic Shunt as a Cause of Unexplained Encephalopathy
Congenital portosystemic shunts can be divided into two types: intrahepatic shunts in which there is an abnormal connection between the branches of the portal vein and either the inferior vena cava or the hepatic veins and less commonly the extrahepatic type in which the portal system is connected to one of the branches of the mesenteric veins. Here we describe a 73-year-old woman who was admitted to the hospital with clinical evidence of encephalopathy and was found to have hyperammonemia. Abdominal computed tomography angiography was performed and revealed a dilated portal vein measuring up to 1.8 cm at the porta-hepatis along with dilated superior mesenteric and splenic veins. Multiple dilated vascular channels were identified within the right hepatic lobe. An intrahepatic portosystemic shunt between an enlarged middle hepatic vein and two separate branches of the right portal vein was demonstrated. A liver biopsy showed normal architecture with no evidence of inflammation or fibrosis. Portosystemic shunts are rare and often detected in adulthood but should be considered as an important cause of unexplained encephalopathy in the absence of cirrhotic liver disease or hepatic trauma. Given that the size of such shunts increases with age, older persons are more prone to the effect of toxic metabolites. This age-associated increase in shunt size may help explain why some patients remain asymptomatic until later in their life which may account for the late presentation in our patient.
- 11 April 2020
- Published by Springer Nature in Cureus
- Vol. 12 (4) , e7639
Open AccessAn Interesting Case of Congenital Intrahepatic Porto-hepatic Shunt as a Cause of Unexplained Encephalopathy
Congenital portosystemic shunts can be divided into two types: intrahepatic shunts in which there is an abnormal connection between the branches of the portal vein and either the inferior vena cava or the hepatic veins and less commonly the extrahepatic type in which the portal system is connected to one of the branches of the mesenteric veins. Here we describe a 73-year-old woman who was admitted to the hospital with clinical evidence of encephalopathy and was found to have hyperammonemia. Abdominal computed tomography angiography was performed and revealed a dilated portal vein measuring up to 1.8 cm at the porta-hepatis along with dilated superior mesenteric and splenic veins. Multiple dilated vascular channels were identified within the right hepatic lobe. An intrahepatic portosystemic shunt between an enlarged middle hepatic vein and two separate branches of the right portal vein was demonstrated. A liver biopsy showed normal architecture with no evidence of inflammation or fibrosis. Portosystemic shunts are rare and often detected in adulthood but should be considered as an important cause of unexplained encephalopathy in the absence of cirrhotic liver disease or hepatic trauma. Given that the size of such shunts increases with age, older persons are more prone to the effect of toxic metabolites. This age-associated increase in shunt size may help explain why some patients remain asymptomatic until later in their life which may account for the late presentation in our patient.
- 3 October 2019
- Published by Taylor & Francis in Expert Review of Gastroenterology & Hepatology
- Vol. 13 (10) , 995-1007
Imaging in discriminating intestinal tuberculosis and Crohn’s disease: past, present and the future
Introduction: Intestinal tuberculosis (ITB) and Crohn’s disease (CD) have similar clinical presentation, but require different treatment approaches. Despite advances in various endoscopic, imaging, microbiological and histological techniques, the differentiation of these two entities is often difficult. Newer radiological and image acquisition modalities have now become indispensable tools for evaluation of these two diseases. Areas covered: This review summarizes the currently available literature on various radiological investigations to differentiate ITB from CD. This review also enumerates the newer modalities in image acquisition techniques and their potential role for differentiating these two diseases. At present abdominal computed tomography (CT) scan is used as a first line investigation for differentiating ITB from CD. Magnetic resonance imaging (MRI) is preferred in pediatric patients and for follow-up studies. Expert Opinion: Role of newer modalities like contrast enhanced abdominal ultrasound, perfusion CT, advanced MRI and positron emission tomography (PET) is evolving and requires further exploration. Till further robust studies are available, differentiation between ITB and CD requires use of a combination of clinical, endoscopic, serological, histological and radiological parameters rather than relying on a single test.
- 3 October 2019
- Published by Taylor & Francis in Expert Review of Gastroenterology & Hepatology
- Vol. 13 (10) , 995-1007
Imaging in discriminating intestinal tuberculosis and Crohn’s disease: past, present and the future
Introduction: Intestinal tuberculosis (ITB) and Crohn’s disease (CD) have similar clinical presentation, but require different treatment approaches. Despite advances in various endoscopic, imaging, microbiological and histological techniques, the differentiation of these two entities is often difficult. Newer radiological and image acquisition modalities have now become indispensable tools for evaluation of these two diseases. Areas covered: This review summarizes the currently available literature on various radiological investigations to differentiate ITB from CD. This review also enumerates the newer modalities in image acquisition techniques and their potential role for differentiating these two diseases. At present abdominal computed tomography (CT) scan is used as a first line investigation for differentiating ITB from CD. Magnetic resonance imaging (MRI) is preferred in pediatric patients and for follow-up studies. Expert Opinion: Role of newer modalities like contrast enhanced abdominal ultrasound, perfusion CT, advanced MRI and positron emission tomography (PET) is evolving and requires further exploration. Till further robust studies are available, differentiation between ITB and CD requires use of a combination of clinical, endoscopic, serological, histological and radiological parameters rather than relying on a single test.
- 1 October 2019
- Published by Elsevier in Annals of Emergency Medicine
- Vol. 74 (4) , e75-e76
Young Female With Pain in the Left Leg
- 1 October 2019
- Published by Elsevier in Annals of Emergency Medicine
- Vol. 74 (4) , e75-e76
Young Female With Pain in the Left Leg
- 1 October 2019
- Published by Elsevier in Medical Hypotheses
- Vol. 131, 109287
A potential role of toll-like receptors, IFN-γ and the phosphatidylinositol 3-kinase pathway in the pathogenesis of acquired mediastinal lymphatic malformation
- 1 October 2019
- Published by Elsevier in Medical Hypotheses
- Vol. 131, 109287
A potential role of toll-like receptors, IFN-γ and the phosphatidylinositol 3-kinase pathway in the pathogenesis of acquired mediastinal lymphatic malformation
- 1 August 2019
- Published by Elsevier in The American Journal of Medicine
- Vol. 132 (8) , e656-e657
A Disappearing Lung Mass: Round Pneumonia
- 1 August 2019
- Published by Elsevier in The American Journal of Medicine
- Vol. 132 (8) , e656-e657
A Disappearing Lung Mass: Round Pneumonia
- Open Access
- 17 April 2019
- Published by Springer Nature in Cureus
- Vol. 11 (4) , e4484
Tracheal Inflammatory Myofibroblastoma: A Rare Tumor of the Trachea
Inflammatory myofibroblastic tumors (IMTs), also known as inflammatory pseudotumor are rarely reported in the trachea. Although initially considered benign, with the recent evidence of local recurrence after surgical resection, cases of metastatic spread, and advance in cytogenetic analysis, they are now categorized as tumors with malignant potential. Correct histological diagnosis is of utmost importance, as they closely resemble other benign and malignant spindle cell tumors with myofibroblasts predominance. Treatment remains challenging taking into account the location involving the airway. Here, we describe a case of tracheal IMF in an apparently healthy young adult presenting with recurrent hemoptysis.
- 17 April 2019
- Published by Springer Nature in Cureus
- Vol. 11 (4) , e4484
Open AccessTracheal Inflammatory Myofibroblastoma: A Rare Tumor of the Trachea
Inflammatory myofibroblastic tumors (IMTs), also known as inflammatory pseudotumor are rarely reported in the trachea. Although initially considered benign, with the recent evidence of local recurrence after surgical resection, cases of metastatic spread, and advance in cytogenetic analysis, they are now categorized as tumors with malignant potential. Correct histological diagnosis is of utmost importance, as they closely resemble other benign and malignant spindle cell tumors with myofibroblasts predominance. Treatment remains challenging taking into account the location involving the airway. Here, we describe a case of tracheal IMF in an apparently healthy young adult presenting with recurrent hemoptysis.
- 1 April 2019
- Published by Elsevier in The American Journal of Medicine
- Vol. 132 (4) , e533-e534
Diabetic Mastopathy Masquerading as Breast Cancer
- 1 April 2019
- Published by Elsevier in The American Journal of Medicine
- Vol. 132 (4) , e533-e534
Diabetic Mastopathy Masquerading as Breast Cancer
- 1 March 2019
- Published by Elsevier in The American Journal of the Medical Sciences
- Vol. 357 (3) , 223-229
Role of Vitamin D and Its Analogues in Diabetic Nephropathy: A Meta-analysis
- 1 March 2019
- Published by Elsevier in The American Journal of the Medical Sciences
- Vol. 357 (3) , 223-229
Role of Vitamin D and Its Analogues in Diabetic Nephropathy: A Meta-analysis